Biodegradable Nanoparticle Mediated Antigen Delivery to Human Cord Blood Derived Dendritic Cells for Induction of Primary T Cell Responses

References

• Agrawal, B., Gendler, S.J. and Longenecker, B.M. (1998a) “The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy”, Mol. Med. Today 4, 397–403.
   Google Scholar
• Agrawal, B., Krantz, M.J., Reddish, M.A. and Longenecker, B.M. (1998b) “Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2”, Nat. Med. 4, 43–49.
   Web of Science ®Google Scholar
• Ahmad-Nejad, P., Hacker, H., Rutz, M., Bauer, S., Vabulas, R.M. and Wagner, H. (2002) “Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments”, Eur. J. Immunol. 32, 1958–1968.
   Web of Science ®Google Scholar
• Antony, P.A. and Restifo, N.P. (2002) “Do CD4þ CD25þ immun- oregulatory T cells hinder tumor immunotherapy?”, J. Immunother. 25, 202–206.
   PubMed Web of Science ®Google Scholar
• Banchereau, J. and Steinman, R.M. (1998) “Dendritic cells and the control of immunity”, Nature 392, 245–252.
   PubMed Web of Science ®Google Scholar
• Boes, M., Bertho, N., Cerny, J., Op den Brouw, M., Kirchhausen, T. and Ploegh, H. (2003) “T cells induce extended class II MHC compartments in dendritic cells in a toll-like receptor-dependent manner”, J. Immunol. 171, 4081–4088.
   Google Scholar
• Borras, F.E., Matthews, N.C., Patel, R. and Navarrete, C. (2000) “Dendritic cells can be successfully generated from CD34þ cord blood cells in the presence of autologous cord blood plasma”, Bone Marrow Transplant. 26, 371–376.
   PubMed Web of Science ®Google Scholar
• Brossart, P., Wirths, S., Brugger, W. and Kanz, L. (2001) “Dendritic cells in cancer vaccines”, Exp. Hematol. 29, 1247–1255.
   Web of Science ®Google Scholar
• Burgess, D.J., Hussain, A.S., Ingallinera, T.S. and Chen, M.L. (2002) “Assuring quality and performance of sustained and controlled release parenterals: AAPS workshop report, co-sponsored by FDA and USP”, Pharm. Res. 19, 1761–1768.
   Google Scholar
• Caux, C., Dezutter-Dambuyant, C., Schmitt, D. and Banchereau, J. (1992) “GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells”, Nature 360, 258–261.
   PubMed Web of Science ®Google Scholar
• Caux, C., Liu, Y.J. and Banchereau, J. (1995) “Recent advances in the study of dendritic cells and follicular dendritic cells”, Immunol. Today 16, 2–4.
   Google Scholar
• Caux, C., Vanbervliet, B., Massacrier, C., Dezutter-Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D. and Banchereau, J. (1996) “CD34þ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSFþ TNF alpha”, J. Exp. Med. 184, 695–706.
   PubMed Web of Science ®Google Scholar
• Coates, P.T. and Thomson, A.W. (2002) “Dendritic cells, tolerance induction and transplant outcome”, Am. J. Transplant. 2, 299–307.
   Google Scholar
• Davies, P. and Allison, A.C. (1978) “Effects of cytochalasin B on endocytosis and exocytosis”, Front. Biol. 46, 143–160.
   Google Scholar
• Dilioglou, S., Cruse, J.M. and Lewis, R.E. (2003) “Costimulatory function of umbilical cord blood CD14þ and CD34þ derived dendritic cells”, Exp. Mol. Pathol. 75, 18–33.
   Google Scholar
• Diwan, M., Dawar, H. and Talwar, G.P. (1998) “Induction of early and bioeffective antibody response in rodents with the luteinizing hormone-releasing hormone vaccine given as a single dose in biodegradable microspheres along with alum”, Prostate 35, 279–284.
   PubMed Web of Science ®Google Scholar
• Diwan, M., Tafagodhi, M. and Samuel, J. (2002) “Enhancement of immune responses by co-delivery of a CpG oligodeoxynucleotide and tetanus toxoid in biodegradable nanospheres”, J. Control. Release 85, 247–262.
   Google Scholar
• Domenech, E., Villen, E., Gonzalez-Barca, E., Querol, S., Garcia, J. and Rueda, F. (2000) “Serum-free culture conditions for the generation of dendritic cells from cord blood CD34þ hematopoietic progenitors: phenotypic and functional analysis”, Haematologica 85, 989–990.
   PubMedGoogle Scholar
• Enomoto, M., Nagayama, H., Sato, K., Xu, Y., Asano, S. and Takahashi, T.A. (2000) “In vitro generation of dendritic cells derived from cryopreserved CD34þ cells mobilized into peripheral blood in lymphoma patients”, Cytotherapy 2, 95–104.
   PubMed Web of Science ®Google Scholar
• French, L.E. and Tschopp, J. (2002) “Defective death receptor signaling as a cause of tumor immune escape”, Semin. Cancer Biol. 12, 51–55.
   PubMed Web of Science ®Google Scholar
• Gendler, S.J. (2001) “MUC1, the renaissance molecule”, J. Mammary Gland Biol. Neoplasia 6, 339–353.
   PubMed Web of Science ®Google Scholar
• Gimmi, C.D., Morrison, B.W., Mainprice, B.A., Gribben, J.G., Boussiotis, V.A., Freeman, G.J., Park, S.Y., Watanabe, M., Gong, J., Hayes, D.F., Kufe, D.W. and Nadler, L.M. (1996) “Breast cancer- associated antigen, DF3/MUC1, induces apoptosis of activated human T cells”, Nat. Med. 2, 1367–1370.
   Web of Science ®Google Scholar
• Hacker, H. (2000) “Signal transduction pathways activated by CpG- DNA”, Curr. Top. Microbiol. Immunol. 247, 77–92.
   PubMed Web of Science ®Google Scholar
• Hackstein, H., Morelli, A.E. and Thomson, A.W. (2001) “Designer dendritic cells for tolerance induction: guided not misguided missiles”, Trends Immunol. 22, 437–442.
   PubMed Web of Science ®Google Scholar
• Hagihara, M., Li, C., Gansuvd, B., Munkhbat, B., Inoue, H., Shimakura, Y., Tsuchiya, T., Ueda, Y., Oki, M., Ando, K., Kato, S. and Hotta, T. (2001) “Extensive and long-term ex vivo production of dendritic cells from CD34 positive umbilical cord blood or bone marrow cells by novel culture system using mouse stroma”, J. Immunol. Methods 253, 45–55.
   PubMed Web of Science ®Google Scholar
• Hart, D.N. (2001) “Dendritic cells and their emerging clinical applications”, Pathology 33, 479–492.
   PubMed Web of Science ®Google Scholar
• Henderson, R.A., Konitsky, W.M., Barratt-Boyes, S.M., Soares, M., Robbins, P.D. and Finn, O.J. (1998) “Retroviral expression of MUC-1 human tumor antigen with intact repeat structure and capacity to elicit immunity in vivo”, J. Immunother. 21, 247–256.
   Web of Science ®Google Scholar
• Horng, T., Barton, G.M., Flavell, R.A. and Medzhitov, R. (2002) “The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors”, Nature 420, 329–333.
   PubMed Web of Science ®Google Scholar
• Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S. and Hartmann, G. (2002) “Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides”, J. Immunol. 168, 4531–4537.
   Web of Science ®Google Scholar
• Ismaili, J., Rennesson, J., Aksoy, E., Vekemans, J., Vincart, B., Amraoui, Z., Van Laethem, F., Goldman, M. and Dubois, P.M. (2002) “Monophosphoryl lipid A activates both human dendritic cells and T cells”, J. Immunol. 168, 926–932.
   Web of Science ®Google Scholar
• Janeway, C.A., Jr. and Medzhitov, R. (2002) “Innate immune recognition”, Ann. Rev. Immunol. 20, 197–216.
   Google Scholar
• Jeannon, J.P., Stafford, F.W., Soames, J.V. and Wilson, J.A. (2001) “Altered MUC1 and MUC2 glycoprotein expression in laryngeal cancer”, Otolaryngol. Head Neck Surg. 124, 199–202.
   Google Scholar
• Johansen, P., Men, Y., Merkle, H.P. and Gander, B. (2000) “Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination”, Eur. J. Pharm. Biopharm. 50, 129–146.
   Google Scholar
• Kadowaki, N., Ho, S., Antonenko, S., Malefyt, R.W., Kastelein, R.A., Bazan, F. and Liu, Y.J. (2001) “Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens”, J. Exp. Med. 194, 863–869.
   PubMed Web of Science ®Google Scholar
• Kaisho, T. and Akira, S. (2001) “Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice”, Trends Immunol. 22, 78–83.
   PubMed Web of Science ®Google Scholar
• Krieg, A.M. (2002) “CpG motifs in bacterial DNA and their immune effects”, Ann. Rev. Immunol. 20, 709–760.
   Google Scholar
• Krieg, A.M. (2003) “CpG motifs: the active ingredient in bacterial extracts?”, Nat. Med. 9, 831–835.
   Web of Science ®Google Scholar
• Krug, A., Towarowski, A., Britsch, S., Rothenfusser, S., Hornung, V., Bals, R., Giese, T., Engelmann, H., Endres, S., Krieg, A.M. and
   Google Scholar
• Hartmann, G. (2001) “Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12”, Eur. J. Immunol. 31, 3026–3037.
   Web of Science ®Google Scholar
• Lenert, P., Stunz, L., Yi, A.K., Krieg, A.M. and Ashman, R.F. (2001) “CpG stimulation of primary mouse B cells is blocked by inhibitory oligodeoxyribonucleotides at a site proximal to NF-kappa B activation”, Antisense Nucleic Acid Drug. Dev. 11, 247–256.
   Web of Science ®Google Scholar
• Lipscomb, M.F. and Masten, B.J. (2002) “Dendritic cells: immune regulators in health and disease”, Physiol. Rev. 82, 97–130.
   Google Scholar
• Liu, A., Takahashi, M., Narita, M., Zheng, Z., Kanazawa, N., Abe, T., Nikkuni, K., Furukawa, T., Toba, K., Fuse, I. and Aizawa, Y. (2002) “Generation of functional and mature dendritic cells from cord blood and bone marrow CD34þ cells by two-step culture combined with calcium ionophore treatment”, J. Immunol. Methods 261, 49–63.
   PubMed Web of Science ®Google Scholar
• Lu, L. and Thomson, A.W. (2002) “Manipulation of dendritic cells for tolerance induction in transplantation and autoimmune disease”, Transplantation 73, S19–S22.
   Google Scholar
• Lutsiak, M.E., Robinson, D.R., Coester, C., Kwon, G.S. and Samuel, J. (2002) “Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro”, Pharm. Res. 19, 1480–1487.
   Google Scholar
• Mahanty, S., Hutchinson, K., Agarwal, S., Mcrae, M., Rollin, P.E. and Pulendran, B. (2003) “Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses”, J. Immunol. 170, 2797–2801.
   Web of Science ®Google Scholar
• Matsuda, K., Masaki, T., Watanabe, T., Kitayama, J., Nagawa, H., Muto, T. and Ajioka, Y. (2000) “Clinical significance of MUC1 and MUC2 mucin and p53 protein expression in colorectal carcinoma”, Jap. J. Clin. Oncol. 30, 89–94.
   Web of Science ®Google Scholar
• McDermott, K.M., Crocker, P.R., Harris, A., Burdick, M.D., Hinoda, Y., Hayashi, T., Imai, K. and Hollingsworth, M.A. (2001) “Over- expression of MUC1 reconfigures the binding properties of tumor cells”, Int. J. Cancer 94, 783–791.
   PubMed Web of Science ®Google Scholar
• Medzhitov, R. and Janeway, C.A. (2002) “Decoding the patterns of self and nonself by the innate immune system”, Science 296, 298–300.
   PubMed Web of Science ®Google Scholar
• Moll, H. and Berberich, C. (2001) “Dendritic cells as vectors for vaccination against infectious diseases”, Int. J. Med. Microbiol. 291, 323–329.
   Web of Science ®Google Scholar
• Moser, M. (2003) “Dendritic cells in immunity and tolerance-do they display opposite functions?”, Immunity 19, 5–8.
   PubMed Web of Science ®Google Scholar
• Newman, K.D., Sosnowski, D.L., Kwon, G.S. and Samuel, J. (1998) “Delivery of MUC1 mucin peptide by Poly(D,L-lactic-co-glycolic acid) microspheres induces type 1 T helper immune responses”, J. Pharm. Sci. 87, 1421–1427.
   PubMed Web of Science ®Google Scholar
• Newman, K.D., Elamanchili, P., Kwon, G.S. and Samuel, J. (2002) “Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo”, J. Biomed. Mater. Res. 60, 480–486.
   PubMed Web of Science ®Google Scholar
• Obermair, A., Schmid, B.C., Packer, L.M., Leodolter, S., Birner, P., Ward, B.G., Crandon, A.J., McGuckin, M.A. and Zeillinger, R. (2002) “Expression of MUC1 splice variants in benign and malignant ovarian tumours”, Int. J. Cancer 100, 166–171.
   PubMed Web of Science ®Google Scholar
• Pecher, G., Haring, A., Kaiser, L. and Thiel, E. (2002) “Mucin gene (MUC1) transfected dendritic cells as vaccine: results of a phase I/II clinical trial”, Cancer Immunol. Immunother. 51, 669–673.
   Web of Science ®Google Scholar
• Probst, H.C., Lagnel, J., Kollias, G. and van den Broek, M. (2003) “Inducible transgenic mice reveal resting dendritic cells as potent inducers of CD8þ T cell tolerance”, Immunity 18, 713–720.
   PubMed Web of Science ®Google Scholar
• Reid, C.D., Fryer, P.R., Clifford, C., Kirk, A., Tikerpae, J. and Knight, S.C. (1990) “Identification of hematopoietic progenitors of macrophages and dendritic Langerhans cells (DL-CFU) in human bone marrow and peripheral blood”, Blood 76, 1139-1149. Reinhard, G., Marten, A., Kiske, S.M., Feil, F., Bieber, T. and Schmidt-Wolf, I.G. (2002) “Generation of dendritic cell-based vaccines for cancer therapy”, Br. J. Cancer 86, 1529–1533.
   Google Scholar
• Rougier, N., Redziniak, G., Schmitt, D. and Vincent, C. (1998) “Evaluation of the capacity of dendritic cells derived from cord blood CD34þ precursors to present haptens to unsensitized autologous T cells in vitro”, J. Investig. Dermatol. 110, 348–352.
   PubMed Web of Science ®Google Scholar
• Sadanaga, N., Nagashima, H., Mashino, K., Tahara, K., Yamaguchi, H., Ohta, M., Fujie, T., Tanaka, F., Inoue, H., Takesako, K., Akiyoshi, T. and Mori, M. (2001) “Dendritic cell vaccination with MAGE peptide is a novel therapeutic approach for gastrointestinal carcinomas”, Clin. Cancer Res. 7, 2277–2284.
   Web of Science ®Google Scholar
• Samuel, J., Budzynski, W.A., Reddish, M., Ding, L., Zimmermann, G., Krantz, M., Koganty, R.R. and Longenecker, B.M. (1998) “Immunogenicity and antitumor activity of a liposomal MUC1 peptide based vaccine”, Int. J. Cancer 75, 295–302.
   PubMed Web of Science ®Google Scholar
• Singh, M. and O’Hagan, D.T. (2002) “Recent advances in vaccine adjuvants”, Pharm. Res. 19, 715–728.
   Google Scholar
• Sinha, V.R. and Trehan, A. (2003) “Biodegradable microspheres for protein delivery”, J. Control. Release 90, 261–280.
   PubMed Web of Science ®Google Scholar
• Steinman, R.M. (1991) “The dendritic cell system and its role in immunogenicity”, Annu. Rev. Immunol. 9, 271–296.
   Google Scholar
• Steinman, R.M. and Dhodapkar, M. (2001) “Active immunization against cancer with dendritic cells: the near future”, Int. J. Cancer 94, 459–473.
   PubMed Web of Science ®Google Scholar
• Stift, A., Friedl, J., Dubsky, P., Bachleitner-Hofmann, T., Schueller, G., Zontsich, T., Benkoe, T., Radelbauer, K., Brostjan, C., Jakesz, R. and Gnant, M. (2003) “Dendritic cell-based vaccination in solid cancer”, J. Clin. Oncol. 21, 135–142.
   Web of Science ®Google Scholar
• Strunk, D., Rappersberger, K., Egger, C., Strobl, H., Kromer, E., Elbe, A., Maurer, D. and Stingl, G. (1996) “Generation of human dendritic cells/Langerhans cells from circulating CD34þ hematopoietic progenitor cells”, Blood 87, 1292–1302.
   PubMed Web of Science ®Google Scholar
• Takeda, K., Kaisho, T. and Akira, S. (2003) “Toll-like receptors”, Annu. Rev. Immunol. 21, 335–376.
   Google Scholar
• Thomas, R. and Lipsky, P.E. (1994) “Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells”, J. Immunol. 153, 4016–4028.
   PubMed Web of Science ®Google Scholar
• Verthelyi, D. and Zeuner, R.A. (2003) “Differential signaling by CpG DNA in DCs and B cells: not just TLR9”, Trends Immunol. 24, 519–522.
   PubMed Web of Science ®Google Scholar
• Vicari, A.P., Caux, C. and Trinchieri, G. (2002) “Tumour escape from immune surveillance through dendritic cell inactivation”, Semin. Cancer Biol. 12, 33–42.
   PubMed Web of Science ®Google Scholar
• von Mensdorff-Pouilly, S., Snijdewint, F.G., Verstraeten, A.A., Verheijen, R.H. and Kenemans, P. (2000) “Human MUC1 mucin: a multifaceted glycoprotein”, Int. J. Biol. Markers 15, 343–356.
   PubMed Web of Science ®Google Scholar
• Walter, E., Dreher, D., Kok, M., Thiele, L., Kiama, S.G., Gehr, P. and Merkle, H.P. (2001) “Hydrophilic poly(D,L-lactide-co-glycolide) microspheres for the delivery of DNA to human-derived macrophages and dendritic cells”, J. Control. Release 76, 149-168. Wang, L.R., Shi, B., Cui, J.Y., Han, S.X., Wang, S.W. and Chen, J.L. (2002) “Dendritic cells cultured with human umbilical cord serum instead of fetal calf serum”, Zhongguo Shi Yan Xue Ye Xue Za Zhi 10, 236–239.
   Google Scholar
• Yamamoto, M., Sato, S., Hemmi, H., Sanjo, H., Uematsu, S., Kaisho, T., Hoshino, K., Takeuchi, O., Kobayashi, M., Fujita, T., Takeda, K. and Akira, S. (2002) “Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4”, Nature 420, 324–329.
   PubMed Web of Science ®Google Scholar
• Yao, V., Platell, C. and Hall, J.C. (2002) “Dendritic cells”, A. N. Z. J. Surg. 72, 501–506.
   Google Scholar
• Zhou, Y., Bosch, M.L. and Salgaller, M.L. (2002) “Current methods for loading dendritic cells with tumor antigen for the induction of antitumor immunity”, J. Immunother. 25, 289–303.
   PubMed Web of Science ®Google Scholar